Spatiotemporal Regulation of GPCR Signaling by Different Beta-Arrestin Conformations
Spatiotemporal Regulation of GPCR Signaling by Different Beta-Arrestin Conformations
批准号:
10682474
负责人:
Alex Rojas Bie Thomsen
金额:
$40.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-08-31
关键词:
AgonistArrestinsBindingBinding SitesBiochemicalBiologicalC-terminalCell surfaceCellsComplexCouplingCyclic AMPDataDrug PrescriptionsDrug TargetingEndocytosisEndosomesFutureG Protein-Coupled Receptor SignalingG protein coupled receptor kinaseG-Protein-Coupled ReceptorsGTP-Binding Protein RegulatorsGTP-Binding ProteinsHeterotrimeric GTP-Binding ProteinsHydrophobicityKnowledge acquisitionLocationMediatingMembraneMolecularMolecular ConformationPhosphorylationPhosphorylation SitePhysiologicalPhysiological ProcessesPropertyProteomicsRegulationResearchSignal TransductionSignaling ProteinTailTherapeuticTimeVisionbeta-arrestindesensitizationdesigndriving forcedrug developmentinnovationphosphoric diester hydrolaseprogramsreceptorreceptor internalizationrecruitresponsespatiotemporal
中文摘要
点击翻译按钮获取中文摘要
英文摘要
G protein-coupled receptors (GPCRs) at the cell surface regulate most physiological processes and are
important drug targets with ~34% of all prescribed drugs targeting them. Classically, upon agonist stimulation,
GPCRs activate heterotrimeric G proteins, causing downstream signaling throughout the cell. In order to
terminate G protein signaling, cells have devised a specialized desensitization mechanism that includes receptor
phosphorylation by GPCR kinases and subsequent recruitment of β-arrestins (βarrs) to the phosphorylated
receptors. The GPCR–βarrs interaction both blocks the G protein-binding site at the receptor core and promotes
receptor endocytosis. Recently, however, we discovered that some GPCRs interact with βarrs exclusively
through their phosphorylated C-terminal tails. Since βarrs do not block the G protein-binding site in this `tail'
conformation, the receptor can associate with βarrs and G proteins simultaneously to form GPCR–G protein–
βarr `megaplexes.' The assembly of these megaplexes allows the receptor to continue to stimulate G protein
signaling while being internalized into endosomes by βarrs. Thus, the existence of the core and tail GPCR–βarr
complex conformations suggests that βarrs act as spatiotemporal master regulators of G protein signaling: When
bound to the receptor core, βarrs regulate the duration of G protein signaling whereas βarrs control the cellular
location from where G proteins are activated from when associated with the receptor C-terminal tail. As the
underlying properties that promote these two complex conformations remain elusive, my research objectives
over the next 5 years involve determining these molecular driving forces on a general scale. Our preliminary data
suggest that phosphorylation site clusters located within the receptor C-terminal tail are required for the
association with βarrs in the tail conformation. Therefore, we plan to establish whether the presence of these
phosphorylation site clusters correlates with the capacity of GPCRs to engage in mechanisms that lead to
sustained endosomal G protein signaling. In regards to the GPCR–βarr core conformation, the fingerloop domain
(FLD) of βarrs inserts itself into the transmembrane core of most GPCRs via its hydrophobic tip and receptor-
specific residues. To characterize this interaction on a general scale, we will examine whether these receptor-
specific βarr-FLD residues correlate with G protein subtype coupling of different GPCRs. Finally, βarrs modulate
the activity of phosphodiesterases (PDEs), which terminate Gs-cAMP signaling. However, our preliminary data
raise the possibility that this modulation occurs specifically by βarrs in the core conformation. Therefore, we will
apply a combination of cell biological, biochemical, and proteomics approaches to examine whether modulation
of PDEs and other desensitization mechanism is mediated specifically by distinct βarr conformations. My vision
with this research program is to elucidate how GPCR signaling is regulated spatiotemporally by βarrs, which
may lead to differentiated physiological responses. The knowledge acquired here will be used to design new and
innovative therapeutics that specifically target GPCRs in time and space.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
β-arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor.
β-arrestin 依赖和独立的内体 G 蛋白由加压素 2 型受体激活。
DOI:
10.1101/2023.04.01.535208
发表时间:
2023
期刊:
bioRxiv : the preprint server for biology
影响因子:
--
作者:
[Daly,Carole, Guseinov,AkimAbdul, Hahn,Hyunggu, Wright,Adam, Tikhonova,IrinaG, Thomsen,AlexRojasBie, Plouffe,Bianca]
通讯作者:
Plouffe,Bianca
Regulation of Melanoma Cell Malignancy by Compartmentalized Chemokine Receptor Signaling
-
批准号:10528741
-
项目类别:
-
资助金额:$41.27万
-
财政年份:2022
-
负责人:Alex Rojas Bie Thomsen
-
依托单位:
Spatiotemporal Regulation of GPCR Signaling by Different Beta-Arrestin Conformations
-
批准号:10501076
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2022
-
负责人:Alex Rojas Bie Thomsen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
AT1R-G蛋白/β-arrestins通路偏好性激活在急性肾损伤中的作用及其机制
-
批准号:82104272
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:贾英丽
-
依托单位:
催产素受体Gαq与β-arrestins偏爱型信号通路在产后抑郁症中的作用
-
批准号:82104148
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:朱佳蕾
-
依托单位:
β-arrestins在DC细胞迁移及自身免疫疾病中的作用及机制研究
-
批准号:31871404
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:杜昌升
-
依托单位:
β-arrestins调节小胶质细胞M1/M2表型转化及其在阿尔兹海默病进程中的作用
-
批准号:81703488
-
项目类别:青年科学基金项目
-
资助金额:20.1万元
-
批准年份:2017
-
负责人:方吟荃
-
依托单位:
β-arrestins保护心肌梗死的作用和机制研究
-
批准号:81670260
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2016
-
负责人:刘冲
-
依托单位:
beta-arrestins在自感光神经节细胞光信号转导中的作用和机制研究
-
批准号:31601134
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:赵欢
-
依托单位:
支气管上皮细胞恶性转化中β-arrestins的作用及其机制研究
-
批准号:81301728
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:申洪昌
-
依托单位:
β-arrestins通过ER stress/Puma调控门脉高压性胃病的机制
-
批准号:81370511
-
项目类别:面上项目
-
资助金额:75.0万元
-
批准年份:2013
-
负责人:吴斌
-
依托单位:
β-arrestins介导甘丙肽2型受体信号转导的作用机理及其可能的抗抑郁机制
-
批准号:31171032
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:徐志卿
-
依托单位:
β-arrestins在缺血再灌注性肝损伤及其修复中的作用和机制
-
批准号:81170422
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:汪根树
-
依托单位: